Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Glycoconj J ; 37(6): 755-765, 2020 12.
Article in English | MEDLINE | ID: mdl-32965647

ABSTRACT

In this paper we characterize the function of Xylosyltransferase 2 (XylT2) in different tissues to investigate the role XylT2 has in the proteoglycan (PG) biochemistry of multiple organs. The results show that in all organs examined there is a widespread and significant decrease in total XylT activity in Xylt2 knock out mice (Xylt2-/-). This decrease results in increased organ weight differences in lung, heart, and spleen. These findings, in addition to our previous findings of increased liver and kidney weight with loss of serum XylT activity, suggest systemic changes in organ function due to loss of XylT2 activity. The Xylt2-/- mice have splenomegaly due to enlargement of the red pulp area and enhanced pulmonary response to bacterial liposaccharide. Tissue glycosaminoglycan composition changes are also found. These results demonstrate a role of XylT2 activity in multiple organs and their PG content. Because the residual XylT activity in the Xylt2-/- is due to xylosyltransferase 1 (XylT1), these studies indicate that both XylT1 and XylT2 have important roles in PG biosynthesis and organ homeostasis.


Subject(s)
Homeostasis/genetics , Pentosyltransferases/genetics , Proteoglycans/genetics , Splenomegaly/genetics , Animals , Humans , Liver/growth & development , Liver/metabolism , Mice , Mice, Knockout , Pentosyltransferases/deficiency , Proteoglycans/metabolism , Splenomegaly/enzymology , Splenomegaly/pathology , UDP Xylose-Protein Xylosyltransferase
2.
PLoS One ; 6(10): e25480, 2011.
Article in English | MEDLINE | ID: mdl-21998662

ABSTRACT

As C-Xyloside has been suggested to be an initiator of glycosaminoglycan (GAG) synthesis, and GAGs such as Dermatan sulfate (DS) are potent enhancers of fibroblast growth factor (FGF)--10 action, we investigated if a C-Xylopyranoside derivative, (C-ß-D-xylopyranoside-2-hydroxy-propane, C-Xyloside), could promote DS production by cultured normal human keratinocytes, how this occurs and if C-Xyloside could also stimulate FGF-dependent cell migration and proliferation. C-Xyloside-treated keratinocytes greatly increased secretion of total sulfated GAGs. Majority of the induced GAG was chondroitin sulfate/dermatan sulfate (CS/DS) of which the major secreted GAG was DS. Cells lacking xylosyltransferase enzymatic activity demonstrated that C-Xyloside was able to stimulate GAG synthesis without addition to core proteins. Consistent with the observed increase in DS, keratinocytes treated with C-Xyloside showed enhanced migration in response to FGF-10 and secreted into their culture media GAGs that promoted FGF-10-dependent cellular proliferation. These results indicate that C-Xyloside may enhance epithelial repair by serving as an initiator of DS synthesis.


Subject(s)
Cell Movement/drug effects , Dermatan Sulfate/biosynthesis , Glycosides/chemistry , Glycosides/pharmacology , Keratinocytes/cytology , Keratinocytes/metabolism , Animals , CHO Cells , Cell Proliferation/drug effects , Cricetinae , Cricetulus , Culture Media, Conditioned/pharmacology , Dermatan Sulfate/metabolism , Fibroblast Growth Factor 10/metabolism , Humans , Keratinocytes/drug effects , Mutation , Pentosyltransferases/deficiency , UDP Xylose-Protein Xylosyltransferase
SELECTION OF CITATIONS
SEARCH DETAIL
...